Old Web
English
Sign In
Acemap
>
Paper
>
Discovery of Lanraplenib (GS-9876), a Once Daily Spleen Tyrosine Kinase Inhibitor for the Treatment of Autoimmune Diseases
Discovery of Lanraplenib (GS-9876), a Once Daily Spleen Tyrosine Kinase Inhibitor for the Treatment of Autoimmune Diseases
2020
Kevin S. Currie
Peter Blomgren
Jayaraman Chandrasekhar
Julie DiPaolo
G. Geng
Carmen Ip
Randall Mark Jones
Jeffrey E. Kropf
Eric B. Lansdon
Seung H. Lee
Jennifer R. Lo
Scott A. Mitchell
Bernard P. Murray
C. Pohlmeyer
Aaron C. Schmitt
Kimberly Suekawa-Pirrone
Sarah Wise
Jin Ming-xiong
Jianjun Xu
Helen Yu
Zhongdong Zhao
Keywords:
Immune system
Pharmacology
Syk
Biology
once daily
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]